API 0.74% $1.35 australian pharmaceutical industries limited

News: API confident in Priceline growth , page-5

  1. 4,717 Posts.
    lightbulb Created with Sketch. 37
    I think you have answered your query on the other thread about why the share price strength - i think it has all to do with priceline and the announcement at the start of this thread!!

    takes a while for new business models to gather momentum and i think that is what we are talking really ( i am not an expert in retail or pharmacy)- speaking of pharmacists, i think on the whole they are pretty conservative so making that switch would not be a decision taken lightly!!
 
watchlist Created with Sketch. Add API (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.